[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW202444425A - 抗ror1抗體與pbd類化合物的偶聯物、其製備方法及其應用 - Google Patents

抗ror1抗體與pbd類化合物的偶聯物、其製備方法及其應用 Download PDF

Info

Publication number
TW202444425A
TW202444425A TW113110867A TW113110867A TW202444425A TW 202444425 A TW202444425 A TW 202444425A TW 113110867 A TW113110867 A TW 113110867A TW 113110867 A TW113110867 A TW 113110867A TW 202444425 A TW202444425 A TW 202444425A
Authority
TW
Taiwan
Prior art keywords
antibody
pharmaceutical use
drug conjugates
ror1
ror1 antibody
Prior art date
Application number
TW113110867A
Other languages
English (en)
Inventor
楊春鵬
尤凌峰
屈博磊
蔡曉鋒
Original Assignee
大陸商江蘇恆瑞醫藥股份有限公司
大陸商上海恆瑞醫藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商江蘇恆瑞醫藥股份有限公司, 大陸商上海恆瑞醫藥有限公司 filed Critical 大陸商江蘇恆瑞醫藥股份有限公司
Publication of TW202444425A publication Critical patent/TW202444425A/zh

Links

Abstract

本揭露涉及抗ROR1抗體與PBD類化合物的偶聯物、其製備方法及其應用。
TW113110867A 2023-03-23 2024-03-22 抗ror1抗體與pbd類化合物的偶聯物、其製備方法及其應用 TW202444425A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2023103033186 2023-03-23

Publications (1)

Publication Number Publication Date
TW202444425A true TW202444425A (zh) 2024-11-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3991754A4 (en) ANTIBODY-DRUG CONJUGATE, INTERMEDIATE THEREOF, METHOD OF PRODUCTION THEREOF AND USE THEREOF
EP3783025A4 (en) TARGETED CD73 ANTIBODY AND ANTIBODY-DRUG CONJUGATE, METHOD FOR PREPARATION THEREOF AND USES THEREOF
WO2018098269A3 (en) Peptide-containing linkers for antibody-drug conjugates
EP3808773A4 (en) AXL-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE, METHOD FOR PREPARING IT, AND USE THEREOF
EP4190812A4 (en) ANTI-CD79B ANTIBODY-DRUG CONJUGATE AND MANUFACTURING PROCESS THEREOF AND PHARMACEUTICAL USE THEREOF
WO2007106744A8 (en) Anti-5t4 antibodies and uses thereof
WO2004043430A3 (en) Botulinum toxin formulations for oral administration
WO2007024536A3 (en) Process for preparing maytansinoid antibody conjugates
WO2021044208A8 (en) Antibody-drug conjugate comprising antibody against human ror1, and use for the same
WO2020236841A3 (en) Antibody drug conjugates having linkers comprising hydrophilic groups
HK1155070A1 (zh) 抗- 抗體-藥物共軛物以及它們在治療癌症和免疫性疾病方面的用途
IL167532A (en) An isolated polysaccharide-containing beta-1,6-glucosamine polymer compound, the preparation containing the isolated polysaccharide associated with a carrier compound, a method for making the isolated polysaccharide, a pharmaceutical preparation, the use of an isolated polysaccharide in the preparation of an antibody, an antibody production method, and a method for producing antibody and antibody.
EP1519192A3 (en) Hiv protease inhibitor conjugates and antibodies useful in immunoassay
EP3936150A4 (en) ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF
EP3907223A4 (en) PROCESS FOR PRODUCTION OF DRUG TOXIN PNU-159682 AN ANTIBODY DRUG CONJUGATE AND INTERMEDIATE THEREOF
EP4069297A4 (en) ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
AU2003302235A1 (en) Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
ZA202201988B (en) Antibody-sting agonist conjugates and their use in immunotherapy
EP3753952A4 (en) EGFRVIII ANTIBODY AND CONJUGATE, METHOD FOR THE PREPARATION AND USE THEREOF
EP4153241A4 (en) CONJUGATION DEVICE AND METHOD FOR PRODUCING CONJUGATES
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
EP4045534A4 (en) ANTIBODIES, PHARMACEUTICAL COMPOSITION AND METHOD
WO2004004639A3 (en) A novel stable formulation
TW202444425A (zh) 抗ror1抗體與pbd類化合物的偶聯物、其製備方法及其應用
UY27458A1 (es) Tetrahidroquinolinas